Get the Stockscreener App
2.18
2.24%
-0.05
Mdxhealth Sa stock is traded at $2.18, with a volume of 44,763.
It is down -2.24% in the last 24 hours and up +6.86% over the past month.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
See More
Previous Close:
$2.23
Open:
$2.22
24h Volume:
44,763
Relative Volume:
0.72
Market Cap:
$106.91M
Revenue:
$63.69M
Net Income/Loss:
$-44.82M
P/E Ratio:
-1.09
EPS:
-2
Net Cash Flow:
$-30.56M
1W Performance:
+7.39%
1M Performance:
+6.86%
6M Performance:
-2.68%
1Y Performance:
-11.74%
1-Day Range:
$2.15
$2.24
1-Week Range:
$1.90
$2.24
52-Week Range:
$1.35
$3.50
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
2.18 | 106.91M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
412.12 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
201.46 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
527.78 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.42 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.16 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-24 | Initiated | Lake Street | Buy |
| May-31-23 | Initiated | TD Cowen | Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Mdxhealth Sa Stock (MDXH) Latest News
Citadel Advisors LLC Sells 40,324 Shares of MDxHealth SA (NASDAQ:MDXH) - Defense World
mdxhealth sa reschedules extraordinary general meeting for june 27 By Investing.com - Investing.com India
mdxhealth sa reschedules extraordinary general meeting for june 27 - Investing.com
MDxHealth Schedules Second EGM for Share Option Plan Approval - TipRanks
Northern Trust Corp Takes $1.03 Million Position in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth (NASDAQ:MDXH) Upgraded to Hold at Wall Street Zen - Defense World
What is William Blair’s Forecast for MDxHealth Q3 Earnings? - Defense World
MDxHealth SA (NASDAQ:MDXH) Q1 2025 Earnings Call Transcript - Insider Monkey
MDxHealth Earnings Call: Growth Amid Financial Challenges - TipRanks
MDxHealth SA (MDXH) Reports Q1 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... - Yahoo Finance
MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Rev - GuruFocus
MDxHealth Reports Strong Q1 2025 Revenue Growth - TipRanks
MDxHealth ADR earnings missed by $0.01, revenue topped estimates - Investing.com India
MDxHealth SA reports results for the quarter ended March 31Earnings Summary - TradingView
MDxHealth Reports Q1 2025 Financial Results with Increased Revenue but Continued Losses - TipRanks
MDxHealth Reports Q1-2025 Results - The Manila Times
MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead o - GuruFocus
MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance
MDXHEALTH SA Earnings Preview: Recent $MDXH Insider Trading, Hedge Fund Activity, and More - Nasdaq
MDxHealth (MDXH) Projected to Post Quarterly Earnings on Wednesday - Defense World
MDxHealth Reports Strong Financial Turnaround in 2024 - TipRanks
Renaissance Technologies LLC Boosts Stake in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth Schedules Key Shareholders’ Meetings for May 2025 - TipRanks
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight - GlobeNewswire Inc.
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 - The Manila Times
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 | Nation/World | bdtonline.com - Bluefield Daily Telegraph
MDxHealth SA Announces Promising Research Results with New Liquid Biopsy Test in Development - marketscreener.com
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Bleichroeder LP's Strategic Acquisition of MDxHealth SA Shares - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Short Interest Up 133.8% in February - Defense World
Oppenheimer & Co. Inc. Has $47,000 Holdings in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth CEO acquires company shares worth $80,000 By Investing.com - Investing.com Australia
MDxHealth stock hits 52-week low at $1.49 amid market challenges - Investing.com Canada
MDxHealth stock hits 52-week low at $1.49 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth CEO acquires company shares worth $80,000 - Investing.com India
Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH) - Yahoo Finance
Research Analysts Issue Forecasts for MDxHealth Q1 Earnings - Defense World
What is William Blair’s Forecast for MDxHealth Q1 Earnings? - Defense World
MDxHealth SA (MDXH) Reports Q4 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN
Mdxhealth S.A. Reports Strong Revenue Growth in Earnings Call - TipRanks
MDxHealth (NASDAQ:MDXH) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Q4 2024 Earnings Call Transcript - Insider Monkey
Mdxhealth fourth quarter revenue grows 28% to USD 24.7M - Medical Buyer
MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Yahoo Finance
MDxHealth ADR earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
Mdxhealth Sa Stock (MDXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):